Molecular mechanism of c‐Myc and PRPS1/2 against thiopurine resistance in Burkitt's lymphoma

Patients with relapsed/refractory Burkitt's lymphoma (BL) have a dismal prognosis. Current research efforts aim to increase cure rates by identifying high‐risk patients in need of more intensive or novel therapy. The 8q24 chromosomal translocation of the c‐Myc gene, a main molecular marker of B...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Cell Mol Med
Autores principales: Li, Ting, Song, Lili, Zhang, Yingwen, Han, Yali, Zhan, Zhiyan, Xv, Zhou, Li, Yang, Tang, Yuejia, Yang, Yi, Wang, Siqi, Li, Shanshan, Zheng, Liang, Li, Yanxin, Gao, Yijin
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7299692/
https://ncbi.nlm.nih.gov/pubmed/32391636
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.15322
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares